RWD SIG

Purpose

To increase collaboration and enhance awareness of strategies and methodologies applied in the utilization of Real World Data in the pharmaceutical industry.

Objectives

Our objectives include:

  • Facilitate sharing of case studies and experiences in this area
  • Collate and summarise publications, articles, presentations, training
  • Identify emerging news and trends
  • Organise and/or participate in workshops related to RWD
  • Collaborate with key stakeholder groups (EFSPI/PSI, EFPIA, ISPOR,  regulatory and academia)
  • Provide comments on RWD related guidelines, e.g. country-specific methods guidelines, FDA methods guidelines, ISPOR etc.
  • Develop/highlight best practices and recommendations
  • Influence industry practice and acceptance of approaches by regulators and other stakeholders

 

Who we are

NameCompany/Institution
Anny Stari (Chair)GSK
Imi FaghmousKite Gilead
Randi GrønNovo Nordisk
Richard GroveGSK
Claire SmithAstraZeneca
Aijing ShangRoche
Barbara TorlinskaUniversity of Birmingham
Huajun WangGSK

Call for members

Frequency of Meetings

Monthly teleconferences

Upcoming Events

Latest Jobs